165 related articles for article (PubMed ID: 8997595)
1. Dysplastic nevi are a risk factor for uveal melanoma.
Hammer H; Oláh J; Tóth-Molnár E
Eur J Ophthalmol; 1996; 6(4):472-4. PubMed ID: 8997595
[TBL] [Abstract][Full Text] [Related]
2. Are atypical nevi a risk factor for uveal melanoma? A case-control study.
van Hees CL; de Boer A; Jager MJ; Bleeker JC; Kakebeeke HM; Crijns MB; Vandenbroucke JP; Bergman W
J Invest Dermatol; 1994 Aug; 103(2):202-5. PubMed ID: 8040610
[TBL] [Abstract][Full Text] [Related]
3. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous dysplastic naevi: risk factor for uveal melanoma.
Hammer H; Tóth-Molńar E; Oláh J; Dobozy A
Lancet; 1995 Jul; 346(8969):255-6. PubMed ID: 7616832
[No Abstract] [Full Text] [Related]
5. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
Richtig E; Langmann G; Müllner K; Smolle J
Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between intraocular melanoma and cutaneous dysplastic nevi.
Taylor MR; Guerry D; Bondi EE; Shields JA; Augsburger JJ; Lusk EJ; Elder DE; Clark WH; Van Horn M
Am J Ophthalmol; 1984 Oct; 98(4):478-82. PubMed ID: 6486223
[TBL] [Abstract][Full Text] [Related]
7. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.
Zampetti A; Silvestri G; Manco S; Khamis K; Masciullo M; Bianchi ML; Damiani A; Santoro M; Linder D; Bewley A; Feliciani C
J Am Acad Dermatol; 2015 Jan; 72(1):85-91. PubMed ID: 25440959
[TBL] [Abstract][Full Text] [Related]
8. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma.
Roush GC; Nordlund JJ; Forget B; Gruber SB; Kirkwood JM
Prev Med; 1988 May; 17(3):273-9. PubMed ID: 3405984
[TBL] [Abstract][Full Text] [Related]
9. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.
Nordlund JJ; Kirkwood J; Forget BM; Scheibner A; Albert DM; Lerner E; Milton GW
Cancer Res; 1985 Apr; 45(4):1855-61. PubMed ID: 3978645
[TBL] [Abstract][Full Text] [Related]
10. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
Tucker MA; Halpern A; Holly EA; Hartge P; Elder DE; Sagebiel RW; Guerry D; Clark WH
JAMA; 1997 May; 277(18):1439-44. PubMed ID: 9145715
[TBL] [Abstract][Full Text] [Related]
11. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
12. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis.
Weis E; Shah CP; Lajous M; Shields JA; Shields CL
Ophthalmology; 2009 Mar; 116(3):536-543.e2. PubMed ID: 19167086
[TBL] [Abstract][Full Text] [Related]
13. Melanoma risk in individuals with clinically atypical nevi.
Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study.
Seregard S; af Trampe E; Månsson-Brahme E; Kock E; Bergenmar M; Ringborg U
Ophthalmology; 1995 Oct; 102(10):1524-9. PubMed ID: 9097801
[TBL] [Abstract][Full Text] [Related]
16. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
[TBL] [Abstract][Full Text] [Related]
17. On the interplay of telomeres, nevi and the risk of melanoma.
Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors and Relationship of Cutaneous and Uveal Melanocytic Lesions in Monozygotic and Dizygotic Twin Pairs.
Csoma RZ; Tóth-Molnár E; Varga A; Szabó H; Orvos H; Kemény L; Oláh J
PLoS One; 2016; 11(8):e0160146. PubMed ID: 27486750
[TBL] [Abstract][Full Text] [Related]
19. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
20. A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma.
Titus-Ernstoff L; Ernstoff MS; Duray PH; Barnhill RL; Holubkov R; Kirkwood JM
Epidemiology; 1991 May; 2(3):210-4. PubMed ID: 2054404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
